Krystal Biotech Inc.(KRYS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

KRYS Krystal Biotech Inc.

Post-Mkt 12-22 19:34:22 EST

249.61

+8.81

+3.66%

盘后250.00

+0.39+0.16%

18:47 EST

High249.78	Low241.43	Vol256.83K
Open241.43	D1 Closing240.80	Amplitude3.47%
Mkt Cap7.24B	Tradable Cap5.74B	Total Shares29.00M
T/O63.63M	T/O Rate1.12%	Tradable Shares22.98M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"KRYS","market":"US","secType":"STK","nameCN":"Krystal Biotech Inc.","latestPrice":249.61,"timestamp":1766437200000,"preClose":240.8,"halted":0,"volume":256831,"hourTrading":{"tag":"盘后","latestPrice":250,"preClose":249.61,"latestTime":"18:47 EST","volume":7476,"amount":1866104.4704399998,"timestamp":1766447267937},"delay":0,"floatShares":22979893,"shares":28997519,"eps":6.66201,"marketStatus":"Post-Mkt","change":8.81,"latestTime":"12-22 19:34:22 EST","open":241.43,"high":249.78,"low":241.43,"amount":63625848.003299996,"amplitude":0.034676,"askPrice":254.48,"askSize":7,"bidPrice":244.79,"bidSize":8,"shortable":3,"etf":0,"ttmEps":6.66201,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1766451600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1505880000000,"exchange":"NASDAQ","adjPreClose":240.8,"preHourTrading":{"tag":"盘前","latestPrice":243,"preClose":240.8,"latestTime":"08:52 EST","volume":10,"amount":2443.05,"timestamp":1766411529280},"postHourTrading":{"tag":"盘后","latestPrice":250,"preClose":249.61,"latestTime":"18:47 EST","volume":7476,"amount":1866104.4704399998,"timestamp":1766447267937},"volumeRatio":0.729809,"impliedVol":0.3939,"impliedVolPercentile":0.212},"requestUrl":"/m/hq/s/KRYS","defaultTab":"news","newsList":[{"id":"2591250616","title":"December 2025's Top Stocks Estimated To Be Trading Below Their True Worth","url":"https://stock-news.laohu8.com/highlight/detail?id=2591250616","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591250616?lang=en_us&edition=fundamental","pubTime":"2025-12-16 01:08","pubTimestamp":1765818490,"startTime":"0","endTime":"0","summary":"As the U.S. stock market grapples with volatility, driven by concerns over an AI bubble impacting technology stocks and recent interest rate decisions by the Federal Reserve, investors are keenly observing economic indicators for guidance. In such fluctuating conditions, identifying undervalued stocks becomes crucial as they can offer potential opportunities for growth when trading below their intrinsic value amidst broader market uncertainties.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/4132000-choice2-main-header/1585187584767","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4132000-choice2-main-header/1585187584767"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/consumer-durables/nasdaq-crox/crocs/news/december-2025s-top-stocks-estimated-to-be-trading-below-thei","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/consumer-durables/nasdaq-crox/crocs/news/december-2025s-top-stocks-estimated-to-be-trading-below-thei","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PLMR","CROX","IE00B64QTZ34.USD","BK4023","LU1064131342.USD","BK4167","MBLY","COLB","BK4157","LU0274383776.USD","LU1923622291.USD","LU2286300806.USD","BK4124","BK4150","BK4139","IE00BLDYK493.USD","LU2264538146.SGD","BK4107","SDGR","UMBF","LU2211815571.USD","BK4097","SRAD","LU2125909759.SGD","PERF","LU2065731478.USD","LU2125909916.SGD","SG9999004303.SGD","BK4588","BK4127","BK4585","MPAA","BK4211","LU1988902786.USD","BULL","BK4146","KRYS","SGXZ23171101.USD","FSUN","VRNS"],"gpt_icon":0},{"id":"2590366503","title":"Krystal Biotech And 2 Other Growth Stocks Insiders Are Betting On","url":"https://stock-news.laohu8.com/highlight/detail?id=2590366503","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590366503?lang=en_us&edition=fundamental","pubTime":"2025-12-12 19:05","pubTimestamp":1765537538,"startTime":"0","endTime":"0","summary":"As the U.S. stock market experiences a surge following the Federal Reserve's decision to cut interest rates, investors are closely watching growth companies with high insider ownership. In this environment, stocks like Krystal Biotech and others where insiders have significant stakes can be particularly attractive, as they often signal confidence in the company's potential amidst evolving economic conditions.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/krystal-biotech-and-2-other-growth-stocks-insiders-are-betti","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/krystal-biotech-and-2-other-growth-stocks-insiders-are-betti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0650527681.SGD","LU2286300806.USD","LU0082616367.USD","LU0274383776.USD","LU2087625088.SGD","BK4141","NET","LU2290526834.HKD","LU0289961442.SGD","LU0056508442.USD","LU0605514214.HKD","NET.AU","BK4600","NIU.AU","BK4547","SN8","BK4142","LU0472753341.HKD","LU0289739343.SGD","BK4543","BTDR","LU0594300419.USD","H","BK7016","LU2265009873.SGD","LU0719512351.SGD","BK4139","BK4554","ATAT","IE00B19Z9P08.USD","BK4607","NIU","STUB","BK4108","BK4539","LU2250418816.HKD","BK4560","BK4613","BK4192","ONON","BK4096","SES","BK4588","KRYS","BK4091","BK4558","LU0594300179.USD"],"gpt_icon":1},{"id":"2589845885","title":"Krish S. Krishnan, President and CEO, Reports Disposal of Krystal Biotech Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2589845885","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589845885?lang=en_us&edition=fundamental","pubTime":"2025-12-06 07:54","pubTimestamp":1764978855,"startTime":"0","endTime":"0","summary":"Krish S. Krishnan, President and CEO of Krystal Biotech Inc., has reported a disposal of common shares of the company, according to a recent regulatory filing. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Krystal Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 05, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL3T65zT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Krish S. Krishnan, President and CEO, Reports Disposal of Krystal Biotech Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRYS","BK4139"],"gpt_icon":0},{"id":"2585520311","title":"Krystal Biotech (KRYS): Assessing Valuation Following Strong Q3 Results and Global Expansion Moves","url":"https://stock-news.laohu8.com/highlight/detail?id=2585520311","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585520311?lang=en_us&edition=fundamental","pubTime":"2025-11-20 23:27","pubTimestamp":1763652430,"startTime":"0","endTime":"0","summary":"Krystal Biotech (KRYS) is drawing fresh attention after reporting strong third quarter results. The report included higher gross margins and impressive revenue from its VYJUVEK therapy. The company is also expanding into Europe, Asia, and the Middle East.\nSee our latest analysis for Krystal Biotech.\nMomentum has clearly been building for Krystal Biotech. After a quieter start to the year, shares have surged more than 40% over the last 90 days, and the one-year total shareholder return now...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/krystal-biotech-krys-assessing-valuation-following-strong-q3","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/krystal-biotech-krys-assessing-valuation-following-strong-q3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","KRYS"],"gpt_icon":0},{"id":"2584258119","title":"Krystal Biotech Q3 Net Income USD 79.365 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2584258119","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584258119?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:25","pubTimestamp":1763569553,"startTime":"0","endTime":"0","summary":"Nov 03 (Reuters) - Krystal Biotech Q3 product revenue USD 97.8 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 03-NOV-202511:55:00.093 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD6GxmlN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRYS","BK4139"],"gpt_icon":0},{"id":"2583456084","title":"Insiders Favor These 3 Growth Companies With Strong Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2583456084","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583456084?lang=en_us&edition=fundamental","pubTime":"2025-11-13 19:06","pubTimestamp":1763031969,"startTime":"0","endTime":"0","summary":"As the U.S. market experiences mixed movements with the Dow Jones Industrial Average reaching new heights and the Nasdaq showing slight declines, investors are closely watching developments like the potential end of a lengthy government shutdown. In such an environment, growth companies with substantial insider ownership can be particularly appealing, as this often indicates confidence in their long-term prospects amidst fluctuating market conditions.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/insiders-favor-these-3-growth-companies-with-strong-ownershi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/insiders-favor-these-3-growth-companies-with-strong-ownershi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0650527681.SGD","LU2089985449.USD","LU0274383776.USD","BK4173","LU1861215975.USD","LU2087625088.SGD","LU2931357623.SGD","BK4141","LU1988902786.USD","LU0348723411.USD","LU0231459107.USD","ARX","LU2290526834.HKD","LU2360107168.USD","LU0289961442.SGD","BK4585","LU0605514214.HKD","NIU.AU","LU0594300419.USD","BK4543","BTDR","LU2360106780.USD","RBLX","ARX.AU","LU2543165471.USD","BK4139","BK4554","ATAT","NIU","LU1861220207.SGD","BK4539","LU1861559042.SGD","LU2250418816.HKD","LU1861217088.USD","LU1804176565.USD","FTCI","ONON","BK4096","SES","BK4555","KRYS","LU0353189680.USD","BK4091","CRDO","IE00BZ9MQY76.HKD","BK4558","LU0594300179.USD"],"gpt_icon":1},{"id":"2583077373","title":"Krystal Biotech (KRYS): Assessing Valuation Following Strong Earnings Surge and Investor Optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=2583077373","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583077373?lang=en_us&edition=fundamental","pubTime":"2025-11-13 02:29","pubTimestamp":1762972158,"startTime":"0","endTime":"0","summary":"Krystal Biotech (KRYS) just posted third quarter earnings that far outpaced last year. The company reported a sharp jump in net income and earnings per share for both the quarter and year-to-date. This strong performance quickly caught investors’ attention.\nSee our latest analysis for Krystal Biotech.\nAfter this earnings jump, Krystal Biotech's share price quickly reflected renewed optimism, notching a 29.71% share price return year-to-date and a strong 35.93% gain over the last 90 days...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/krystal-biotech-krys-assessing-valuation-following-strong-ea","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/krystal-biotech-krys-assessing-valuation-following-strong-ea","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["KRYS"],"gpt_icon":0},{"id":"2582382726","title":"Investors Shouldn't Be Too Comfortable With Krystal Biotech's (NASDAQ:KRYS) Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2582382726","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582382726?lang=en_us&edition=fundamental","pubTime":"2025-11-10 18:04","pubTimestamp":1762769046,"startTime":"0","endTime":"0","summary":"Krystal Biotech, Inc.'s ( NASDAQ:KRYS ) robust earnings report didn't manage to move the market for its stock. Our...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/investors-shouldnt-be-too-comfortable-with-krystal-biotechs","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/investors-shouldnt-be-too-comfortable-with-krystal-biotechs","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","KRYS",".IXIC"],"gpt_icon":0},{"id":"2581712017","title":"Evercore ISI Sticks to Their Buy Rating for Krystal Biotech (KRYS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581712017","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581712017?lang=en_us&edition=fundamental","pubTime":"2025-11-05 14:16","pubTimestamp":1762323370,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Gavin Clark-Gartner from Evercore ISI maintained a Buy rating on Krystal Biotech, with a price target of $218.00. T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/evercore-isi-sticks-to-their-buy-rating-for-krystal-biotech-krys-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/evercore-isi-sticks-to-their-buy-rating-for-krystal-biotech-krys-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KRYS"],"gpt_icon":0},{"id":"1170276918","title":"Stock Track | Krystal Biotech (KRYS) Soars 5.28% as Chardan Capital Raises Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1170276918","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170276918?lang=en_us&edition=fundamental","pubTime":"2025-11-04 23:36","pubTimestamp":1762270587,"startTime":"0","endTime":"0","summary":"Shares of Krystal Biotech Inc. (KRYS) are soaring 5.28% in Tuesday's trading session, following a positive analyst update from Chardan Capital. The biotechnology company's stock is gaining momentum...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["KRYS"],"gpt_icon":0},{"id":"2580732412","title":"Chardan Raises Price Target on Krystal Biotech to $220 From $216, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2580732412","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580732412?lang=en_us&edition=fundamental","pubTime":"2025-11-04 21:35","pubTimestamp":1762263327,"startTime":"0","endTime":"0","summary":"Krystal Biotech (KRYS) has an average rating of buy and mean price target of $222.46, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ba","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KRYS","BK4139"],"gpt_icon":0},{"id":"2580732450","title":"Krystal Biotech Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2580732450","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580732450?lang=en_us&edition=fundamental","pubTime":"2025-11-04 21:32","pubTimestamp":1762263120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KRYS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 04, 2025 08:32 ET (13:32 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRYS","BK4139"],"gpt_icon":0},{"id":"2580127381","title":"Analysts Are Bullish on Top Healthcare Stocks: Krystal Biotech (KRYS), Xenon (XENE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2580127381","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580127381?lang=en_us&edition=fundamental","pubTime":"2025-11-04 08:50","pubTimestamp":1762217424,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Krystal Biotech (KRYS – Research Report) and Xenon (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-krystal-biotech-krys-xenon-xene-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-krystal-biotech-krys-xenon-xene-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XENE","XBI","XLV","BLSH","BK4588","BK4137","HCSG","BK4585","LABU","LU0029874061.USD","BK4112","LU0128526141.USD","BK4581","KRYS"],"gpt_icon":0},{"id":"2580244458","title":"Krystal Biotech price target raised to $217 from $212 at Clear Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2580244458","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580244458?lang=en_us&edition=fundamental","pubTime":"2025-11-04 03:10","pubTimestamp":1762197053,"startTime":"0","endTime":"0","summary":"Clear Street raised the firm’s price target on Krystal Biotech (KRYS) to $217 from $212 and keeps a Buy rating on the shares after Krystal reported...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/krystal-biotech-price-target-raised-to-217-from-212-at-clear-street-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/krystal-biotech-price-target-raised-to-217-from-212-at-clear-street-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KRYS"],"gpt_icon":0},{"id":"2580231241","title":"Krystal Biotech (KRYS) Gets a Buy from H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2580231241","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580231241?lang=en_us&edition=fundamental","pubTime":"2025-11-04 02:55","pubTimestamp":1762196122,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Krystal Biotech today and set a price target of $240.00. The company’s shares o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/krystal-biotech-krys-gets-a-buy-from-h-c-wainwright-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/krystal-biotech-krys-gets-a-buy-from-h-c-wainwright-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KRYS","BK4139"],"gpt_icon":0},{"id":"1159255953","title":"Stock Track | Krystal Biotech Plummets 5.77% Despite Strong Q3 Earnings, Investors Weigh Future Growth Prospects","url":"https://stock-news.laohu8.com/highlight/detail?id=1159255953","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159255953?lang=en_us&edition=fundamental","pubTime":"2025-11-03 22:33","pubTimestamp":1762180394,"startTime":"0","endTime":"0","summary":"Krystal Biotech Inc. (KRYS) shares plummeted 5.77% in pre-market trading on Monday, despite the company reporting better-than-expected third-quarter earnings. The biotechnology firm, which focuses on...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["KRYS"],"gpt_icon":0},{"id":"2580290641","title":"Krystal Biotech sees FY25 non-GAAP R&D, SG&A expense $145M-$155M","url":"https://stock-news.laohu8.com/highlight/detail?id=2580290641","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580290641?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:12","pubTimestamp":1762171937,"startTime":"0","endTime":"0","summary":"07:05 EST Krystal Biotech (KRYS) sees FY25 non-GAAP R&D, SG&A expense $145M-$155M Published first on TheFly – the ultimate source for real-time, ma...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/krystal-biotech-sees-fy25-non-gaap-rd-sga-expense-145m-155m-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/krystal-biotech-sees-fy25-non-gaap-rd-sga-expense-145m-155m-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KRYS","BK4139"],"gpt_icon":0},{"id":"2580297157","title":"Earnings Flash (KRYS) Krystal Biotech Posts Q3 EPS $2.66, vs. FactSet Est of $0.95","url":"https://stock-news.laohu8.com/highlight/detail?id=2580297157","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580297157?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:05","pubTimestamp":1762171553,"startTime":"0","endTime":"0","summary":"Earnings Flash (KRYS) Krystal Biotech Posts Q3 EPS $2.66, vs. FactSet Est of $0.95","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KRYS"],"gpt_icon":0},{"id":"2580329759","title":"Krystal Biotech Q3 EPS $2.66 Beats $1.03 Estimate, Sales $97.800M Beat $93.186M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2580329759","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580329759?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:01","pubTimestamp":1762171278,"startTime":"0","endTime":"0","summary":"Krystal Biotech (NASDAQ:KRYS) reported quarterly earnings of $2.66 per share which beat the analyst consensus estimate of $1.03 by 158.5 percent. This is a 192.31 percent increase over earnings of $0.91 per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48586504/krystal-biotech-q3-eps-2-66-beats-1-03-estimate-sales-97-800m-beat-93-186m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRYS","BK4139"],"gpt_icon":0},{"id":"2580376297","title":"BRIEF-Krystal Biotech Q3 Net Income USD 79.365 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2580376297","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580376297?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:00","pubTimestamp":1762171247,"startTime":"0","endTime":"0","summary":"BRIEF-Krystal Biotech Q3 Net Income USD 79.365 Million\n\n\nNov 03 (Reuters) - Krystal Biotech Q3 product revenue USD 97.8 million.\n\nQ3 operating income USD 41.374 million\nQ3 operating expenses USD 56.426 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nPLX8C9F10:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRYS","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.krystalbio.com","stockEarnings":[{"period":"1week","weight":-0.0157},{"period":"1month","weight":0.1798},{"period":"3month","weight":0.4722},{"period":"6month","weight":0.8179},{"period":"1year","weight":0.4972},{"period":"ytd","weight":0.5371}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States. It commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). The company also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.003038},{"month":2,"riseRate":0.75,"avgChangeRate":0.093738},{"month":3,"riseRate":0.625,"avgChangeRate":0.050497},{"month":4,"riseRate":0.375,"avgChangeRate":-0.020845},{"month":5,"riseRate":0.5,"avgChangeRate":0.012748},{"month":6,"riseRate":0.75,"avgChangeRate":0.115596},{"month":7,"riseRate":0.75,"avgChangeRate":0.07679},{"month":8,"riseRate":0.125,"avgChangeRate":-0.010983},{"month":9,"riseRate":0.25,"avgChangeRate":-0.037914},{"month":10,"riseRate":0.555556,"avgChangeRate":0.053086},{"month":11,"riseRate":0.888889,"avgChangeRate":0.190014},{"month":12,"riseRate":0.555556,"avgChangeRate":-0.014602}],"exchange":"NASDAQ","name":"Krystal Biotech Inc.","nameEN":"Krystal Biotech Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Krystal Biotech Inc.(KRYS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Krystal Biotech Inc.(KRYS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Krystal Biotech Inc.,KRYS,Krystal Biotech Inc.股票,Krystal Biotech Inc.股票老虎,Krystal Biotech Inc.股票老虎国际,Krystal Biotech Inc.行情,Krystal Biotech Inc.股票行情,Krystal Biotech Inc.股价,Krystal Biotech Inc.股市,Krystal Biotech Inc.股票价格,Krystal Biotech Inc.股票交易,Krystal Biotech Inc.股票购买,Krystal Biotech Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Krystal Biotech Inc.(KRYS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Krystal Biotech Inc.(KRYS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction